Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 22 tags : Positive save search
Protiviti Sees Positive Impact of Golf Brand Ambassador Program On and Off the Course
Published: 2022-06-22 (Crawled : 23:00) - prnewswire.com
RHI | News | $70.23 0.96% 0.0% 1.2M
|
Commercial Services
|
| O: -4.08%
H: 1.09%
C: -2.29%
program positive
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program
Published: 2022-06-22 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 7.12%
H: 0.0%
C: 0.0%
xen1101 program positive update
Athira Puts Positive Spin on Alzheimer’s Trial Despite Missed Endpoint
Published: 2022-06-22 (Crawled : 14:20) - biospace.com/
PPRUF | News | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.6%
H: 5.96%
C: 1.4%
PPRUY | News | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -2.59%
H: 2.19%
C: 1.04%
trial alzheimer’s positive alzheimer's
CymaBay Therapeutics Presents Positive PBC Data at the International Liver Congress™ 2022
Published: 2022-06-22 (Crawled : 13:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 1.97%
H: 18.15%
C: 15.94%
liver therapeutics positive international
IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 1.33%
H: 1.42%
C: -0.62%
us10 positive
BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -1.02%
H: 12.96%
C: 8.61%
bbp-812 pharma disease aav9 positive therapy
Zynerba Pharmaceuticals Announces Positive Top Line Results from Open-Label Phase 2 INSPIRE Trial of Zygel™ in 22q11.2 Deletion Syndrome Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in inno...
Published: 2022-06-22 (Crawled : 10:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 2.73%
H: 6.19%
C: 1.77%
trial positive results zygel topline
B2Gold Announces Positive Exploration Drill Results in Mali from Fekola North and Anaconda Area Exploration Drilling
Published: 2022-06-22 (Crawled : 08:00) - prnewswire.com
BTG | $2.6 -0.38% 0.39% 14M
|
Non-Energy Minerals
|
| O: -0.14%
H: 0.0%
C: 0.0%
positive results
Zynerba Pharmaceuticals Announces Positive Top Line Results from Open-Label Phase 2 INSPIRE Trial of Zygel™ in 22q11.2 Deletion Syndrome
Published: 2022-06-22 (Crawled : 01:00) - globenewswire.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 2.73%
H: 6.19%
C: 1.77%
trial positive results zygel topline phase 2
Gainers vs Losers
| 68% | 32% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.